Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Apremilast Tablets

Approval Number

国药准字H20243529

Company浙江三生蔓迪药业有限公司

Registration Date

April 17, 2024

Drug Information

Generic Name

阿普米司特片

Dosage Form

片剂

Strength

20mg

Drug Type

化学药品

Registration Date

April 17, 2024

Company Information

Applicant Company

Company Name浙江三生蔓迪药业有限公司

Company Address

浙江省杭州市临安区青山湖街道王家山路1号

Manufacturing Company

Company Name浙江三生蔓迪药业有限公司

Company Address

杭州市临安区青山湖街道王家山路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy